Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Van Nuffel, Anouk ^a   Ariën, Kevin K ^a,f   Stove, Veronique ^a   Schindler, Michael ^b,g   O'Neill, Eduardo ^c,h   Schmökel, Jan ^b   Van de Walle, Inge ^a   Naessens, Evelien ^a   Vanderstraeten, Hanne ^a   Van Landeghem, Kathleen ^a   Taghon, Tom ^a   Pulkkinen, Kati ^d   Saksela, Kalle ^d   Garcia, J V ^c,i   Fackler, Oliver T ^e   Kirchhoff, Frank ^b   Verhasselt, Bruno ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CD3; CXCR4; HIV; Nef; PAK2; SIV; Thymus

Indexed keywords

CD3 ANTIGEN; MUTANT PROTEIN; NEF PROTEIN; P21 ACTIVATED KINASE;

ANIMAL TISSUE; ARTICLE; CELL MATURATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRINAE; LENTIVIRUS INFECTION; MOUSE; NONHUMAN; PRIMATE; PROTEIN BINDING; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; STEM CELL; T CELL DEPLETION; T LYMPHOCYTE; THYMOCYTE; THYMUS; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CELL DIFFERENTIATION; MICE; MICE, SCID; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; ORGAN CULTURE TECHNIQUES; T-LYMPHOCYTES; THYMOCYTES; THYMUS GLAND; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84887559691     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-137     Document Type: Article

References (59)

1. Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, Baril JG, Dion H, Lefebvre E, Thomas R, Cote P, Lapointe N, Routy JP, Sekaly RP, Conway B, Bernard NF. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol 2003, 171:477-488.
2. Dion ML, Bordi R, Zeidan J, Asaad R, Boulassel MR, Routy JP, Lederman MM, Sekaly RP, Cheynier R. Slow disease progression and robust therapy-mediated CD4(+) T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood 2007, 109:2912-2920.
3. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 396:690-695. 10.1038/25374, 9872319.
4. Haynes BF, Hale LP, Weinhold KJ, Patel DD, Liao HX, Bressler PB, Jones DM, Demarest JF, Gebhard-Mitchell K, Haase AT, Bartlett JA. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 1999, 103:453-460. 10.1172/JCI5201, 408098, 10021452.
5. Baskin GB, Murpheycorb M, Martin LN, Davisonfairburn B, Hu FS, Kuebler D. Thymus in simian immunodeficiency virus-infected rhesus-monkeys. Lab Invest 1991, 65:400-407.
6. Wykrzykowska JJ, Rosenzweig M, Veazey RS, Simon MA, Halvorsen K, Desrosiers RC, Johnson RP, Lackner AA. Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 1998, 187:1767-1778. 10.1084/jem.187.11.1767, 2212305, 9607918.
7. Sodora DL, Milush JM, Ware F, Wozniakowski A, Montgomery L, McClure HM, Lackner AA, Marthas M, Hirsch V, Johnson RP, Douek DC, Koup RA. Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. J Virol 2002, 76:9981-9990. 10.1128/JVI.76.19.9981-9990.2002, 136511, 12208974.
8. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Importance of the Nef gene for maintenance of high virus loads and for development of aids. Cell 1991, 65:651-662. 10.1016/0092-8674(91)90097-I, 2032289.
9. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludfordmenting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. Genomic structure of an attenuated quasi-species of Hiv-1 from a blood-transfusion donor and recipients. Science 1995, 270:988-991. 10.1126/science.270.5238.988, 7481804.
10. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report - absence of intact Nef sequences in a long-term survivor with nonprogressive Hiv-1 infection. N Engl J Med 1995, 332:228-232. 10.1056/NEJM199501263320405, 7808489.
11. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998, 95:163-175. 10.1016/S0092-8674(00)81748-1, 9790524.
12. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J. Severe immunodeficiency associated with a human-immunodeficiency-virus-1 Nef/3' long terminal repeat transgene. J Exp Med 1994, 179:797-807. 10.1084/jem.179.3.797, 2191393, 8113676.
13. Skowronski J, Parks D, Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 1993, 12:703-713. 413256, 8095017.
14. Arien KK, Verhasselt B. HIV Nef: role in pathogenesis and viral fitness. Curr HIV Res 2008, 6:200-208. 10.2174/157016208784325001, 18473783.
15. Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010, 8:55-67. 10.1016/j.chom.2010.06.004, 20638642.
16. Arhel NJ, Kirchhoff F. Implications of Nef: host cell interactions in viral persistence and progression to AIDS. Curr Top Microbiol Immunol Volume 339 2009, 147-175. Berlin: Springer-Verlag Berlin.
17. Vermeire J, Vanbillemont G, Witkowski W, Verhasselt B. The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection. Curr HIV Res 2011, 9:474-489. 10.2174/157016211798842099, 3355465, 22103831.
18. Landi A, Iannucci V, Van Nuffel A, Meuwissen P, Verhasselt B. One protein to rule them All: modulation of cell surface receptors and molecules by HIV Nef. Curr HIV Res 2011, 9:496-504. 10.2174/157016211798842116, 3290772, 22103833.
19. Feldmann J, Leligdowicz A, Jaye A, Dong T, Whittle H, Rowland-Jones SL. Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does Not protect against disease progression. J Virol 2009, 83:12968-12972. 10.1128/JVI.01252-09, 2786859, 19812166.
20. Foster JL, Molina RP, Luo T, Arora VK, Huang Y, Ho DD, Garcia JV. Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates. J Virol 2001, 75:1672-1680. 10.1128/JVI.75.4.1672-1680.2001, 114076, 11160665.
21. Howe AYM, Jung JU, Desrosiers RC. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol 1998, 72:9827-9834. 110494, 9811718.
22. Munch J, Schindler M, Wildum S, Rucker E, Bailer N, Knoop V, Novembre FJ, Kirchhoff F. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication. J Virol 2005, 79:10547-10560. 10.1128/JVI.79.16.10547-10560.2005, 1182674, 16051847.
23. Schindler M, Wildum S, Casartelli N, Doria M, Kirchhoff F. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors. AIDS 2007, 21:1103-1107. 10.1097/QAD.0b013e32816aa37c, 17502720.
24. Verhasselt B, Naessens E, Verhofstede C, De Smedt M, Schollen S, Kerre T, Vanhecke D, Plum J. Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells. Blood 1999, 94:2809-2818.
25. Stove V, Naessens E, Stove C, Swigut T, Plum J, Verhasselt B. Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development. Blood 2003, 102:2925-2932. 10.1182/blood-2003-03-0833, 12855553.
26. Dorival C, Brizzi F, Lelievre JD, Sol-Foulon N, Six E, Henry A, Andre-Schmutz I, Cavazzana-Calvo M, Coulombel L, Estaquier J, Schwartz O, Levy Y. HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursor. Virol 2008, 377:207-215.
27. Zou W, Denton PW, Watkins RL, Krisko JF, Nochi T, Foster JL, Garcia JV. Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4(+)CD8(+) thymocytes. Retrovirol 2012, 9:44.
28. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006, 125:1055-1067. 10.1016/j.cell.2006.04.033, 16777597.
29. Meuwissen PJ, Stolp B, Iannucci V, Vermeire J, Naessens E, Saksela K, Geyer M, Vanham G, Arien KK, Fackler OT, Verhasselt B. Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function. Retrovirol 2012, 9:34.
30. Kuo LS, Baugh LL, Denial SJ, Watkins RL, Liu MJ, Garcia JV, Foster JL. Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix. Retrovirol 2012, 9:47.
31. Stolp B, Abraham L, Rudolph JM, Fackler OT. Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling. J Virol 2010, 84:3935-3948. 10.1128/JVI.02467-09, 2849517, 20147394.
32. Galabru J, Reycuille MA, Hovanessian AG. Nucleotide-sequence of the HIV-2 EHO genome, a divergent HIV-2 isolate. AIDS Res Hum Retrovir 1995, 11:873-874. 10.1089/aid.1995.11.873, 7546916.
33. Schmokel J, Sauter D, Schindler M, Leendertz FH, Bailes E, Dazza MC, Saragosti S, Bibollet-Ruche F, Peeters M, Hahn BH, Kirchhoff F. The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 Are Not always linked in primate lentiviruses. J Virol 2011, 85:742-752. 10.1128/JVI.02087-10, 3020008, 21068258.
34. Hrecka K, Swigut T, Schindler M, Kirchhoff F, Skowronski J. Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1. J Virol 2005, 79:10650-10659. 10.1128/JVI.79.16.10650-10659.2005, 1182621, 16051857.
35. Schindler M, Rajan D, Specht A, Ritter C, Pulkkinen K, Saksela K, Kirchhoff F. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in Ex vivo-infected human lymphoid tissue. J Virol 2007, 81:13005-13014. 10.1128/JVI.01436-07, 2169106, 17881449.
36. ONeill E, Kuo LS, Krisko JF, Tomchick DR, Garcia JV, Foster JL. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J Virol 2006, 80:1311-1320. 10.1128/JVI.80.3.1311-1320.2006, 1346962, 16415008.
37. Rauch S, Pulkkinen K, Saksela K, Fackler OT. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol 2008, 82:2918-2929. 10.1128/JVI.02185-07, 2259019, 18094167.
38. Carl S, Iafrate AJ, Lang SM, Stolte N, Stahl-Hennig C, Matz-Rensing K, Fuchs D, Skowronski J, Kirchhoff F. Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques. J Virol 2000, 74:4155-4164. 10.1128/JVI.74.9.4155-4164.2000, 111930, 10756028.
39. Schindler M, Munch J, Brenner M, Stahl-Hennig C, Skowronski J, Kirchhoff F. Comprehensive analysis of Nef functions selected in simian immunodeficiency virus-infected macaques. J Virol 2004, 78:10588-10597. 10.1128/JVI.78.19.10588-10597.2004, 516420, 15367626.
40. Arhel N, Lehmann M, Clauss K, Nienhaus GU, Piguet V, Kirchhoff F. The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J Clin Invest 2009, 119:2965-2975. 2752074, 19759518.
41. Agopian K, Wei BL, Garcia JV, Gabuzda D. A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol 2006, 80:3050-3061. 10.1128/JVI.80.6.3050-3061.2006, 1395437, 16501114.
42. Haller C, Rauch S, Fackler OT. HIV-1 Nef employs Two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLOS ONE 2007, 2:e1212. 10.1371/journal.pone.0001212, 2075162, 18030346.
43. Renkema GH, Manninen A, Saksela K. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J Virol 2001, 75:2154-2160. 10.1128/JVI.75.5.2154-2160.2001, 114799, 11160719.
44. Pulkkinen K, Renkema GH, Kirchhoff F, Saksela K. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J Virol 2004, 78:12773-12780. 10.1128/JVI.78.23.12773-12780.2004, 524974, 15542629.
45. Khan IH, Sawai ET, Antonio E, Weber CJ, Mandell CP, Montbriand P, Luciw PA. Role of the SH3-ligand domain of simian immunodeficiency virus nef in interaction with nef-associated kinase and simian AIDS in rhesus macaques. J Virol 1998, 72:5820-5830. 110384, 9621042.
46. ONeill E, Baugh LL, Novitsky VA, Essex ME, Garcia JV. Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 Nef. J Virol 2006, 80:8824-8829. 10.1128/JVI.00910-06, 1563850, 16912329.
47. Blom B, Spits H. Development of human lymphoid cells. Ann Rev Immunol 2006, 24:287-320.
48. Munch J, Janardhan A, Stolte N, Stahl-Hennig C, ten Haaft P, Heeney JL, Swigut T, Kirchhoff F, Skowronski J. T-Cell Receptor: CD3 down-regulation is a selected in vivo function of simian immunodeficiency virus Nef but is not sufficient for effective viral replication in rhesus macaques. J Virol 2002, 76:12360-12364. 10.1128/JVI.76.23.12360-12364.2002, 136863, 12414978.
49. Trampont PC, Tosello-Trampont AC, Shen YL, Duley AK, Sutherland AE, Bender TP, Littman DR, Ravichandran KS. CXCR4 acts as a costimulator during thymic beta-selection. Nature Immunol 2009, 11:162-170.
50. Janas ML, Varano G, Gudmundsson K, Noda M, Nagasawa T, Turner M. Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. J Exp Med 2010, 207:247-261. 10.1084/jem.20091430, 2812547, 20038597.
51. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, Casazza J, Yoder C, Adelsberger JW, Stevens RA, Baseler MW, Keiser P, Richman DD, Davey RT, Koup RA. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001, 167:6663-6668.
52. Stove V, Verhasselt B. Modelling thymic HIV-1 Nef effects. Curr HIV Res 2006, 4:57-64. 10.2174/157016206775197583, 16454711.
53. Taghon T, Yui MA, Pant R, Diamond RA, Rothenberg EV. Developmental and molecular characterization of emerging [beta]- and [gamma][delta]-selected Pre-T cells in the adult mouse thymus. Immunity 2006, 24:53-64. 10.1016/j.immuni.2005.11.012, 16413923.
54. Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 2006, 24:547-561. 10.1016/j.immuni.2006.02.016, 16713973.
55. Pan XY, Rudolph JM, Abraham L, Habermann A, Haller C, Krijnse-Locker J, Fackler OT. HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling. Blood 2012, 119:786-797. 10.1182/blood-2011-08-373209, 22123847.
56. Abraham L, Bankhead P, Pan XY, Engel U, Fackler OT. HIV-1 Nef limits communication between linker of activated T cells and SLP-76 to reduce formation of SLP-76-signaling microclusters following TCR stimulation. J Immunol 2012, 189:1898-1910. 10.4049/jimmunol.1200652, 22802418.
57. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A. Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 2013, 154:1326-1341. 10.1016/j.cell.2013.08.009, 24034254.
58. Chrobak P, Simard MC, Bouchard N, Ndolo TM, Guertin J, Hanna Z, Dave V, Jolicoeur P. HIV-1 Nef disrupts maturation of CD4(+) T cells through CD4/Lck modulation. J Immunol 2010, 185:3948-3959. 10.4049/jimmunol.1001064, 20826747.
59. Verhasselt B, De Smedt M, Verhelst R, Naessens E, Plum J. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 1998, 91:431-440.